title: Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites.
abstract: OBJECTIVE
  AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that acts as an intracellular fuel sensor, directing multiple metabolic pathways in a catabolic direction in times of nutrient shortage. In humans, three different gamma-subunits (gamma(1), gamma(2), gamma(3)) have been identified as AMPK regulators. The AMPKgamma3 (protein kinase, AMP-activated, gamma 3 non-catalytic subunit, PRKAG3) isoform plays a role in gene regulation in glucose/lipid metabolism and skeletal muscle glycogen content. We investigated whether PRKAG3, in addition to being expressed in skeletal muscle, is also expressed in human liver. We also investigated whether genetic variance in PRKAG3 is associated with glucose and/or lipid metabolism in non-diabetic whites.
  
  
  METHODS
  After sequencing a screening cohort (n = 50) in the PRKAG3 locus, we genotyped 1061 participants for frequently found single nucleotide polymorphisms (SNPs). Association analyses between genotypes/haplotypes and metabolic traits were carried out.
  
  
  RESULTS
  We detected PRKAG3 expression in human liver and skeletal muscle. Two SNPs (rs692243, rs6436094) with minor allele frequencies of 0.16 and 0.26 respectively and in moderate linkage disequilibrium (D' = 0.92; r (2) = 0.47) were found. rs692243 (C/G) confers a Pro71Ala mutation, while rs6436094 (A/G) is located in the 3' untranslated region. No associations with prediabetic traits such as body fat distribution, insulin resistance or insulin secretion were found (p > 0.15 for all). However, the minor alleles of both SNPs were significantly associated with higher serum LDL-cholesterol and apolipoprotein (Apo) B-100 levels (rs692243: CG:LDL 4.3%, ApoB-100 3.4%; GG:LDL 7.6%, ApoB-100 5.4%; p = 0.008 and p = 0.01 respectively; rs6436094: AG:LDL 3.3%, ApoB-100 1.7%; GG:LDL 11.3%, ApoB-100 11.1%; p = 0.009 and p = 0.05 respectively; dominant model). The GG/GG diplotype homozygous for both minor SNP alleles displayed the highest LDL-cholesterol among all frequent diplotypes (p = 0.059).
  
  
  CONCLUSIONS
  While genetic variability in PRKAG3 does not seem to have a major effect on glucose metabolism, it may play an important role in lipoprotein metabolism in humans.
authors: Department of Internal Medicine, Division of Endocrinology, Metabolism, Pathobiochemistry and Clinical Chemistry, University of Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
authors: P
authors: P
authors: Weyrich
authors: F
authors: F
authors: Machicao
authors: H
authors: H
authors: Staiger
authors: P
authors: P
authors: Simon
authors: C
authors: C
authors: Thamer
authors: J
authors: J
authors: Machann
authors: F
authors: F
authors: Schick
authors: A
authors: A
authors: Guirguis
authors: A
authors: A
authors: Fritsche
authors: N
authors: N
authors: Stefan
authors: H-U
authors: HU
authors: Häring
mesh_terms: D055372:AMP-Activated Protein Kinases; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D003001:Cloning, Molecular; D018076:DNA, Complementary / Q000235:genetics; D014644:Genetic Variation; D005838:Genotype; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology; D000078790:Insulin Secretion; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008099:Liver / Q000201:enzymology; D009097:Multienzyme Complexes / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D021122:Protein Subunits / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D044465:White People / Q000235:genetics
chemical_list: D001786:Blood Glucose; D018076:DNA, Complementary; D007328:Insulin; D008055:Lipids; D008074:Lipoproteins; D009097:Multienzyme Complexes; D021122:Protein Subunits; C526222:PRKAG1 protein, human; C526225:PRKAG3 protein, human; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases; D005947:Glucose
references: N Engl J Med. 2001 Jun 14;344(24):1823-31
references: 11407343
references: J Biol Chem. 2006 Mar 17;281(11):7244-52
references: 16410251
references: Diabetes. 2006 Mar;55(3):849-55
references: 16505254
references: J Intern Med. 2005 Nov;258(5):395-410
references: 16238675
references: J Clin Invest. 2006 Jul;116(7):1776-83
references: 16823475
references: Diabet Med. 1998 Jul;15(7):539-53
references: 9686693
references: J Clin Endocrinol Metab. 2005 Jul;90(7):4238-43
references: 15855254
references: Diabetologia. 2001 Jul;44(7):824-33
references: 11508266
references: Science. 2000 May 19;288(5469):1248-51
references: 10818001
references: J Biol Chem. 1994 Mar 4;269(9):6810-4
references: 8120043
references: Diabetes Care. 1999 Sep;22(9):1462-70
references: 10480510
references: Diabetes. 1999 May;48(5):1113-9
references: 10331418
references: Nature. 2005 Oct 27;437(7063):1299-320
references: 16255080
references: J Biol Chem. 2006 Nov 24;281(47):36434-42
references: 17012231
references: Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E194-200
references: 14559719
references: J Med Genet. 2006 Dec;43(12):936-42
references: 16801347
references: Diabetologia. 2005 Nov;48(11):2354-64
references: 16237515
references: Nat Clin Pract Cardiovasc Med. 2007 Apr;4(4):214-25
references: 17380167
references: Mol Genet Metab. 2005 Nov;86(3):372-8
references: 16115789
references: BMC Bioinformatics. 2006 Feb 09;7:60
references: 16466584
references: J Clin Invest. 1999 Sep;104(6):787-94
references: 10491414
references: Diabetes Obes Metab. 2006 Nov;8(6):591-602
references: 17026483
references: Biostatistics. 2003 Oct;4(4):513-22
references: 14557108
references: N Engl J Med. 2005 Jan 27;352(4):362-72
references: 15673802
references: J Biol Chem. 2002 Dec 27;277(52):51017-24
references: 12397075
references: Biochim Biophys Acta. 1992 Feb 12;1123(3):231-8
references: 1536860
references: Am J Physiol. 1999 Jul;277(1 Pt 1):E1-10
references: 10409121
references: Am J Hum Genet. 2005 Jun;76(6):1034-49
references: 15877279
references: Biochem Soc Trans. 2003 Feb;31(Pt 1):224-7
references: 12546690
references: Proc Natl Acad Sci U S A. 1979 Oct;76(10):5345-9
references: 228286
references: Diabetes. 2006 Apr;55(4):919-23
references: 16567511
references: Can J Physiol Pharmacol. 2006 Jul;84(7):655-65
references: 16998529
references: Curr Opin Lipidol. 2001 Jun;12(3):261-6
references: 11353328
references: Diabetes. 2005 Dec;54(12):3484-9
references: 16306365
references: Biochem J. 2000 Mar 15;346 Pt 3:659-69
references: 10698692
references: EMBO J. 2000 Mar 1;19(5):819-30
references: 10698924
references: J Biol Chem. 2004 Sep 10;279(37):38441-7
references: 15247217
references: FASEB J. 2005 May;19(7):773-9
references: 15857891
references: J Biol Chem. 1982 Jul 25;257(14):8001-8
references: 6282867